Mary Gribble

Mary Gribble is a seasoned engineer with extensive experience in process development within the biotechnology sector. Currently serving as a Senior Engineer at Obsidian Therapeutics since January 2023, Mary previously held the same position at Rubius Therapeutics from July 2019 to February 2023, where responsibilities included leading a team in upstream development for a RED cell therapy program and supporting multiple IND filings. Prior to that, Mary worked at Biogen in various engineering roles, focusing on gene therapy process development and technology transfer. Additional experience includes a role as Biomedical Engineering Leadership Associate at Nemucore Medical Innovations and a research assistantship at Worcester Polytechnic Institute. Mary holds a Master of Engineering degree in Bioengineering and Biomedical Engineering from Tufts University and a Bachelor of Science in Chemical Engineering from Worcester Polytechnic Institute.